Literature DB >> 17584565

Diastolic function assessment in clinical practice: the value of 2-dimensional echocardiography.

Martin Osranek1, James B Seward, Beatrix Buschenreithner, Jutta Bergler-Klein, Maria Heger, Ursula Klaar, Thomas Binder, Gerald Maurer, Manfred Zehetgruber.   

Abstract

BACKGROUND: The aim of this study was to test the hypothesis that diastolic dysfunction associated with increased filling pressures is unlikely in a structurally normal heart and to assess whether 2-dimensional echocardiography can facilitate diastolic function grading in a clinical setting.
METHODS: Consecutive patients referred for transthoracic echocardiography received a comprehensive Doppler echocardiographic evaluation of diastolic function and measurements of left ventricular ejection fraction (EF) by biplane Simpson's method, left atrial volume index (LAVI) by area-length method, and interventricular septal thickness (IVS) from 2-dimensional images. Patients with atrial fibrillation, cardiac pacemaker, severe mitral regurgitation, or mitral prosthesis were excluded.
RESULTS: Of 187 patients, 38 had normal diastolic function and 77 had grade I; 54, grade II; and 18, grade III diastolic dysfunction. The presence of any 2-dimensional abnormality (EF < 55%, IVS > or = 14 mm, LAVI > or = 40 mL/m2) identified any diastolic dysfunction (grade I-III) with 92.6% sensitivity and 92.1% specificity. In a receiver operating characteristic analysis to predict any diastolic dysfunction, the areas under the receiver operating characteristic curve for EF, IVS, and LAVI and the sum of all 3 abnormalities were 0.69, 0.81, 0.87, and 0.95 (all P < .0001), respectively. Among all patients with at least one abnormality, the probability of diastolic dysfunction was 97.9% (138/141). Interpretation of 2-dimensional abnormalities together with the mitral inflow pattern resulted in correct diastolic function grading in 98.4% (184/187).
CONCLUSIONS: Structural abnormalities on 2-dimensional echocardiography are not only statistically associated with diastolic dysfunction, but the combination of LAVI, EF, and IVS is of practical value for diastolic function grading. The presence of any such 2-dimensional abnormality should be considered indicative of diastolic dysfunction.

Entities:  

Mesh:

Year:  2007        PMID: 17584565     DOI: 10.1016/j.ahj.2007.03.026

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  6 in total

1.  One-point carotid wave intensity predicts cardiac mortality in patients with congestive heart failure and reduced ejection fraction.

Authors:  Olga Vriz; Marco Pellegrinet; Concetta Zito; Vitantonio di Bello; Manola Bettio; Scipione Carerj; Antonello Cittadini; Eduardo Bossone; Francesco Antonini-Canterin
Journal:  Int J Cardiovasc Imaging       Date:  2015-06-23       Impact factor: 2.357

Review 2.  Diastolic dysfunction, cardiovascular aging, and the anesthesiologist.

Authors:  David Sanders; Michael Dudley; Leanne Groban
Journal:  Anesthesiol Clin       Date:  2009-09

3.  Echocardiographic evaluation of diastolic heart failure.

Authors:  Queenie Lo; Liza Thomas
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

4.  Relationship of left ventricular and atrial dimensions with moderate to severe left ventricular diastolic dysfunction (grade II and above).

Authors:  Muhammad Hamza; Mishal Fatima; Muhammad Masood; Hafiz Umar Masood; Ghazal Tasleem; Hassaan Ahmed; Maha Nadir; Zubair Satti
Journal:  Afr Health Sci       Date:  2020-12       Impact factor: 0.927

5.  Association of E/E' and NT-proBNP with renal function in patients with essential hypertension.

Authors:  Yan Yang; Yan Wang; Zhong-wei Shi; Ding-liang Zhu; Ping-jin Gao
Journal:  PLoS One       Date:  2013-01-28       Impact factor: 3.240

6.  Extracellular volume quantification in isolated hypertension - changes at the detectable limits?

Authors:  Thomas A Treibel; Filip Zemrak; Daniel M Sado; Sanjay M Banypersad; Steven K White; Viviana Maestrini; Andrea Barison; Vimal Patel; Anna S Herrey; Ceri Davies; Mark J Caulfield; Steffen E Petersen; James C Moon
Journal:  J Cardiovasc Magn Reson       Date:  2015-08-12       Impact factor: 5.364

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.